Patient info

Sinemet Plus tablets,Sinemet Plus 25 mg / 100 mg tablets – Summary of Product Characteristics (SmPC) for healthcare professionals

Medicine status: Prescription only (POM) Details

Medicine strength:
25 mg + 100 mg
Contains active substances:
ATC code:
Similar medicines:

Sources: Original (products.mhra.gov.uk)

Summary of Product Characteristics (SmPC) - Sinemet Plus tablets,Sinemet Plus 25 mg / 100 mg tablets

4. CLINICAL PARTICULARS

4.1. Therapeutic indications

Not applicable

4.2. Posology and method of administration

Not applicable

4.3. Contrain­dications

Not applicable

4.4. Special warnings and precautions for use

Not applicable

4.5. Interactions with other medicinal products and other forms of interaction

Not applicable

4.6. Pregnancy and lactation

Not applicable

4.7. Effects on ability to drive and use machines

Not applicable

4.8. Undesirable effects

4.9. Overdose

5. PHARMACOLOGICAL PROPERTIES

5.1. Pharmaco­dynamic properties

Not applicable

5.2. Pharmaco­kinetic properties

Not applicable

5.3. Preclinical safety data

Not applicable

Sources: Original (products.mhra.gov.uk)

Facts about Sinemet Plus tablets,Sinemet Plus 25 mg / 100 mg tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substances Levodopa, Carbidopa
Strength 25 mg + 100 mg
Pharmaceutical form Oral tablet
How is it taken Oral
Pack sizes 100 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. N Nervous system drugs
    1. N04 Anti-parkinson drugs
      1. N04B Dopaminergic agents
        1. N04BA Dopa and dopa derivatives
          1. N04BA02 levodopa and decarboxylase inhibitor
Codes GTIN 0840164526400 · BNF 04090100

Sources: the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.